Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cancer Trials Australia (CTA) is an active, not-for-profit member-based clinical research organization specializing in the administration and coordination of oncology and broader therapeutic area clinical trials across Australia and New Zealand. It has supported over 2,200 trials with more than 14,000 patients enrolled since inception. CTA administers >50% of all Phase I oncology trials in Australia and offers comprehensive services from feasibility assessment to post-trial financial management for its network members—comprising major hospitals and research institutes. The organization does not develop drugs itself but enables rapid multi-site recruitment and high-quality data generation for sponsors ranging from global pharma/biotech companies to academic groups.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cancer Trials Australia.